Scheduling Nab-paclitaxel With Gemcitabine

PHASE2CompletedINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Pancreatic Adenocarcinoma Metastatic
Interventions
DRUG

Abraxane (nab-paclitaxel)

DRUG

Gemcitabine

Trial Locations (23)

CB2 0QQ

Cambridge University Hospitals NHS Foundation Trust, Cambridge

PE3 9GZ

Peterborough City Hospital, Peterborough

Unknown

Ysbyty Gwynedd, Bangor

Queen Elizabeth Hospital, Birmingham

Bristol Haematology & Oncology Centre, Bristol

Velindre Cancer Centre, Cardiff

Edinburgh Cancer Research Centre, Edinburgh

The Beatson Oncology Centre, Glasgow

The Royal Surrey County Hospital, Guildford

St James' Institute of Oncology, Leeds

Clatterbridge Cancer Centre, Liverpool

Hammersmith Hospital, London

The Royal Free Hospital, London

University College London Hospital, London

The Christie Hospital, Manchester

Churchill Hospital, Oxford

Weston Park Hospital, Sheffield

Royal Cornwall Hospital, Truro

BT9 7AB

Belfast City Hospital, Belfast

CO4 5JL

Colchester Hospital, Colchester

CV2 2DX

University Hospitals Coventry & Warwickshire, Coventry

LE1 5WW

Leicester Royal Infirmary, Leicester

EC1A 7BE

Barts Health NHS Trust, London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Celgene

INDUSTRY

lead

CCTU- Cancer Theme

OTHER

NCT03529175 - Scheduling Nab-paclitaxel With Gemcitabine | Biotech Hunter | Biotech Hunter